GG 260 (Hydroxychloroquine 200 mg)

Pill imprint GG 260 has been identified as Hydroxychloroquine sulfate 200 mg.

Hydroxychloroquine is used in the treatment of systemic lupus erythematosus; rheumatoid arthritis; sjogren's syndrome; lyme disease, arthritis; undifferentiated connective tissue disease (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GG 260

Hydroxychloroquine sulfate 200 mg GG 260  Front
Hydroxychloroquine sulfate 200 mg GG 260  Back
Hydroxychloroquine sulfate 200 mg GG 260
Hydroxychloroquine sulfate
Imprint:
GG 260
Strength:
200 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimalarial quinolines
Antirheumatics
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-1407
Inactive Ingredients:
calcium phosphate dibasic anhydrous
hydroxypropyl cellulose
hypromelloses
magnesium stearate
polyethylene glycol
povidone
sodium bicarbonate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)